REGINfo: Biogen Idec Inc - Biotechnologie - Financial information

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
> TA 25
Israel - TA 25
- ALONY HETZ
- AZRIELI GROUP
- BAZAN
- BEZEQ
- DELEK DRILLIN
- DELEK GROUP
- DISCOUNT
- ELBIT SYSTEMS
- Energean Oil Gas
- FIBI BANK
- GAZIT GLOBE
- HAREL
- ICL
- IFF
- ISRAEL CORP
- LEUMI
- LivePerson
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- ORMAT
- PAZ OIL
- PERRIGO
- Phoenix Group Holdings
- POALIM
- SHUFERSAL
- STRAUSS GROUP
- TEVA
- TOWER JAZZ

Europe

S&P 100 NEWS

> Accenture PLC

> Adobe Systems Inc

> Allstate Corp.

> Altria Group, Inc.

> Amazon.com Inc

> American Express

> American International Group

> Bank of America

> Bank of New York Mellon Corp

> Berkshire Hathaway Inc.

> Biogen Idec Inc

> Booking Holdings

> Bristol-Myers Squibb Co.

> Caterpillar Inc.

> Charter Communication

> Cisco Systems Inc

> Coca Cola Co.

> Colgate-Palmolive

> ConocoPhillips

> Costco Wholesale Corp

> CVS Caremark Corp.

> Eli Lilly & Co.

> Emerson Electric Co.

> Exelon Corporation

> Exxon Mobil Corp.

> Ford Motor Company

> General Dynamics

> General Electric

> General Motors

> Gilead Sciences Inc

> Goldman Sachs Group, Inc.

> Home Depot, Inc

> Honeywell International, Inc.

> International Business Machines (IBM)

> Johnson & Johnson

> JP Morgan Chase & Co

> Kinder Morgan Inc

> Lockheed Martin

> Lowes Companies

> Mastercard Inc A

> McDonald's Corp.

> Medtronic, Inc.

> Merck & Co., Inc.

> Mondelez International Inc

> Morgan Stanley

> NextEra Energy Inc

> Occidental Petroleum

> ...

FEEDS

My Google

Microsoft Live

My Yahoo

COMPANY SEARCH RESULT

$Biogen Idec Inc: Click to view the issuer\'s details$

Last update : 21/08/2018 >View issuer details

2021.07.23 | 22:30 | Permanent Information Releases / General Company News

puce Biogen to Present Data from ADUHELM and Alzheimer’s Disease Portfolio at 2021 Alzheimer’s Association International Conference - HTML (w)

2021.07.22 | 13:05 | Permanent Information Releases / General Company News

puce An open letter to the Alzheimer’s disease community from our Head of Research and Development, Alfred Sandrock, M.D., Ph.D. - HTML (w)

2021.07.13 | 01:00 | Permanent Information Releases / General Company News

puce Biogen and Innocare Announce License and Collaboration Agreement For Orelabrutinib, an Innovative CNS Penetrant BTK Inhibitor For the Potential Treatment of Multiple Sclerosis - HTML (w)

2021.07.08 | 22:06 | Permanent Information Releases / General Company News

puce Collaboration Between AbbVie, Biogen and Pfizer Creates World’s Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease - HTML (w)

2021.07.08 | 13:30 | Permanent Information Releases / General Company News

puce FDA Approves Updated ADUHELM™ Prescribing Information to Emphasize Population Studied in Clinical Trials - HTML (w)

2021.06.25 | 13:30 | Permanent Information Releases / General Company News

puce Samsung Bioepis and Biogen Receive Positive CHMP Opinion for Ranibizumab Biosimilar, BYOOVIZ™ - HTML (w)

2021.06.17 | 13:30 | Permanent Information Releases / General Company News

puce Biogen Announces First Patient Dosed in Phase 3 Systemic Lupus Erythematosus Study - HTML (w)

2021.06.16 | 22:30 | Permanent Information Releases / Sales and Revenues

puce Biogen Announces Topline Results From Phase 2 Study of Gosuranemab, an Anti-Tau Antibody, for Alzheimer’s Disease - HTML (w)

2021.06.15 | 12:30 | Permanent Information Releases / General Company News

puce Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder - HTML (w)

2021.06.14 | 22:06 | Permanent Information Releases / Sales and Revenues

puce Biogen Announces Topline Results from Phase 3 Gene Therapy Study in Choroideremia - HTML (w)

2021.06.10 | 13:30 | Permanent Information Releases / General Company News

puce New Data at Cure SMA 2021 Highlight the Long-Term Efficacy of SPINRAZA® (nusinersen) and Biogen’s Commitment to Innovation in SMA Therapy - HTML (w)

2021.06.07 | 19:01 | Permanent Information Releases / General Company News

puce Biogen and Eisai launch multiple initiatives to help patients with Alzheimer’s disease access ADUHELM™ - HTML (w)

2021.06.07 | 19:00 | Permanent Information Releases / General Company News

puce FDA grants accelerated approval for ADUHELM™ as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease - HTML (w)

2021.06.01 | 13:30 | Periodic information / 1st Quarter Information

puce Biogen and Bio-Thera Announce Positive Results From Phase 3 Study of BAT1806, a Proposed Biosimilar Referencing Actemra® (Tocilizumab) - HTML (w)

2021.05.21 | 13:30 | Permanent Information Releases / General Company News

puce Biogen and Ginkgo Bioworks Announce Collaboration and License Agreement to Develop Novel Gene Therapy Manufacturing Platform - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 157